Tag: animal gastroesophageal reflux disease market share

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Animal Gastroesophageal Reflux Disease Market Forecast: What Value Will The Market Reach By 2030?

The animal gastroesophageal reflux disease market size has experienced significant expansion over recent years. It is projected to increase from $1.98 billion in 2025 to $2.16 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.8%. The historic period’s growth can be attributed to several factors, including limited awareness of animal GERD among veterinarians, a high prevalence of GERD in companion animals, a lack of advanced diagnostics in veterinary hospitals, reliance on generic medications, and the expansion of veterinary clinics and hospitals.

The animal gastroesophageal reflux disease market is anticipated to experience robust expansion over the next few years. It is projected to achieve a size of $2.99 billion by 2030, progressing at a compound annual growth rate (CAGR) of 8.5%. This growth during the forecast period is attributable to the emergence of advanced diagnostic techniques like endoscopy and manometry, a heightened emphasis on nutritional and dietary interventions, the increasing uptake of over-the-counter and prescription drugs, the growth of veterinary e-commerce channels, and the incorporation of artificial intelligence and digital platforms for customized treatment. Significant trends foreseen in this period include the rising use of endoscopy and pH monitoring for GERD diagnosis, the increased application of nutritional supplements and dietary adjustments in management, an expansion in the availability of prescription and over-the-counter medications for companion animals, the broadening of minimally invasive surgical options for GERD treatment, and the implementation of customized treatment protocols for both livestock and companion animals.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=20464&type=smp&name=Animal%20Gastroesophageal%20Reflux%20Disease%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Animal Gastroesophageal Reflux Disease Market Expansion Drivers: What’s Shaping Future Growth?

The animal gastroesophageal reflux disease market is anticipated to expand due to the rising humanization of pets. This trend involves pet owners increasingly regarding their animals as members of the family, assigning them human-like feelings, requirements, and actions. Such humanization is fueled by stronger emotional connections developing between pets and their owners. Consequently, there is a greater need for advanced healthcare services, high-quality diets, and well-being products comparable to those for humans. The phenomenon of pet humanization also raises awareness about conditions like gastroesophageal reflux disease (GERD), encouraging owners to pursue veterinary attention and increasing the need for diagnostic tools, therapeutic interventions, and prophylactic measures. For instance, in April 2024, according to the American Pet Products Association, a US-based not-for-profit industry association, 86.9 million households in the US had a pet in 2023-2024, accounting for 66% of households, up from 62% in 2022. Thus, the expanding humanization of pets is a key factor propelling the animal gastroesophageal reflux disease market forward.

Animal Gastroesophageal Reflux Disease Market Breakdown By Product Type And Application

The animal gastroesophageal reflux disease market covered in this report is segmented –

1) By Product: Treatment, Diagnostics

2) By Mode: Over-The-Counter (OTC), Prescription

3) By Route Of Administration: Oral, Injectable

4) By Animal: Companion Animals, Livestock Animal

5) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, E-Commerce

Subsegments:

1) By Treatment: Medications, Surgical Interventions, Dietary Modifications, Nutritional Supplements, Antacids

2) By Diagnostics: Endoscopy, Esophageal pH Monitoring, Manometry, Ultrasound, Radiographic Studies, Biopsy Techniques

Animal Gastroesophageal Reflux Disease Market Strategic Trends: What Defines The Next Growth Phase?

Leading companies in the animal gastroesophageal reflux disease market are formulating specialized diets that support gastrointestinal health, aiming to enhance digestive function and manage symptoms of gastroesophageal reflux disease in pets. Gastrointestinal support diets represent specifically crafted pet foods designed to alleviate and control the manifestations of various gastrointestinal conditions. These dietary programs typically incorporate easily digestible components, balanced nutrients, and often include added fibers or probiotics to foster digestive wellness and overall vitality. For example, in April 2024, Royal Canin, a USA-based subsidiary of Mars Incorporated and a producer of cat and dog food, expanded its veterinary gastrointestinal (GI) portfolio by introducing five new diets focused on improving the gastrointestinal health of pets. These particular diets, developed in partnership with researchers, veterinarians, and specialists, are engineered to address GI issues in both dogs and cats, encompassing food-responsive sensitivities and fat-restricted dietary needs. The new range includes choices such as gastrointestinal low-fat, hydrolyzed protein canine, and gastrointestinal hydrolyzed protein feline, all formulated with highly digestible ingredients to promote long-term gastrointestinal health.

Animal Gastroesophageal Reflux Disease Market Company Landscape And Competitive Strategy

Major companies operating in the animal gastroesophageal reflux disease market are Zoetis Inc., VCA Animal Hospitals, Petco Health and Wellness Company Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Hill’s Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Santé Animale, Virbac S.A., Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Blue Buffalo Company Ltd., Vetoquinol S.A., Antech Diagnostics, Heska Corporation, WellPet LLC, McNeil Consumer Pharmaceuticals Co., Wag Labs Inc. , VetPartners Limited, BioZyme Inc., Zomedica Corp., NexGen Pharmaceuticals LLC

View The Full Animal Gastroesophageal Reflux Disease Market Report:

https://thebusinessresearchcompany.com/report/animal-gastroesophageal-reflux-disease-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Animal Gastroesophageal Reflux Disease Market Largest Region: Which Geography Holds The Biggest Share?

North America was the largest region in the animal gastroesophageal reflux disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal gastroesophageal reflux disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Trend Is Expected For The Animal Gastroesophageal Reflux Disease Market From 2026 To 2030?

The animal gastroesophageal reflux disease market has shown significant expansion in recent years. Its size is anticipated to rise from $1.98 billion in 2025 to $2.16 billion in 2026, driven by a compound annual growth rate (CAGR) of 8.8%. Factors contributing to its historical growth include limited awareness of animal gerd among veterinarians, high prevalence of gerd in companion animals, lack of advanced diagnostics in veterinary hospitals, reliance on generic medications, and the growth of veterinary clinics and hospitals.

The animal gastroesophageal reflux disease market is projected to experience substantial expansion over the upcoming years. By 2030, its value is forecast to reach $2.99 billion, exhibiting a compound annual growth rate (CAGR) of 8.5%. This anticipated growth during the forecast period is fueled by several factors, including the advancement of diagnostic techniques like endoscopy and manometry, a heightened emphasis on nutritional and dietary interventions, the increasing uptake of otc and prescription drugs, the broadening of veterinary e-commerce channels, and the incorporation of ai and digital platforms for tailored treatment. Key trends during the forecast period encompass a growing reliance on endoscopy and ph monitoring for gerd diagnosis, increased application of nutritional supplements and dietary modifications in management, an increase in the availability of prescription and otc medication for companion animals, the broadening scope of minimally invasive surgical interventions for gerd treatment, and the development of customized treatment protocols for livestock and companion animals.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20464&type=smp

What Major Growth Factors Are Impacting The Animal Gastroesophageal Reflux Disease Market?

The increasing humanization of pets is expected to propel the growth of the animal gastroesophageal reflux disease market. Humanization of pets refers to the growing trend where pet owners treat their animals more like human family members, attributing human-like emotions, needs, and behaviors to them. The likeness of pets’ humanization is driven by the growing emotional bonds between owners and their pets. This increases the demand for specialized healthcare, premium diets, and wellness products that mirror human standards. The humanization of pets heightens awareness of health issues such as gastroesophageal reflux disease (GERD), prompting more attentive owners to seek veterinary care and driving demand for diagnostics, treatments, and preventive options. For instance, in April 2024, according to the American Pet Products Association, a US-based not-for-profit industry association, 86.9 million households in the US had a pet in 2023-2024, accounting for 66% of households, up from 62% in 2022. Therefore, the increasing humanization of pets is driving the growth of the animal gastroesophageal reflux disease market.

Animal Gastroesophageal Reflux Disease Market Driver: Surge In Animal Healthcare Spending Fueling The Growth Of The Market Due To Increasing Preventive And Advanced Veterinary Care

The rising spending on animal healthcare is expected to propel the growth of the animal gastroesophageal reflux disease market going forword. Animal healthcare is the care and treatment given to animals to prevent diseases, diagnose health problems, provide medical treatment, and maintain their overall health and well-being throughout their lives. Spending on animal healthcare is rising because pet owners are increasingly prioritizing preventive and advanced medical care to improve the quality and longevity of their animals’ lives, leading to higher use of veterinary services, diagnostics, and treatments. Animal gastroesophageal reflux disease increases spending on animal healthcare by requiring repeated veterinary consultations, diagnostic tests, long-term medication, and dietary management to control symptoms and prevent complications. For instance, in March 2025, according to the American Pet Products Association, US-based non-profit organization, within total spending in 2024, $39.8 billion was spent on Veterinary Care & Product Sales. Therefore, the rising spending on animal healthcare is driving the growth of the animal gastroesophageal reflux disease market.

Which Segment Divisions Form The Structure Of The Animal Gastroesophageal Reflux Disease Market?

The animal gastroesophageal reflux disease market covered in this report is segmented –

1) By Product: Treatment, Diagnostics

2) By Mode: Over-The-Counter (OTC), Prescription

3) By Route Of Administration: Oral, Injectable

4) By Animal: Companion Animals, Livestock Animal

5) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, E-Commerce

Subsegments:

1) By Treatment: Medications, Surgical Interventions, Dietary Modifications, Nutritional Supplements, Antacids

2) By Diagnostics: Endoscopy, Esophageal pH Monitoring, Manometry, Ultrasound, Radiographic Studies, Biopsy Techniques

What Trends Are Shaping The Animal Gastroesophageal Reflux Disease Market Structure?

Major companies operating in the animal gastroesophageal reflux disease market are developing specialized diets that support gastrointestinal diets to improve digestive health and manage symptoms of gastroesophageal reflux disease in pets. Gastrointestinal support diets are specially formulated pet foods designed to manage and alleviate symptoms of gastrointestinal disorders. These diets typically include easily digestible ingredients, balanced nutrients, and added fibers or probiotics to promote digestive health and overall well-being. For instance, in April 2024, Royal Canin, a USA-based subsidiary of Mars Incorporated and manufacturer of cat and dog food, expanded its veterinary gastrointestinal (GI) portfolio by introducing five new diets designed to improve the gastrointestinal health of pets. These specialized diets, developed in collaboration with researchers, veterinarians, and specialists, focus on addressing GI issues in both dogs and cats, including food-responsive sensitivities and fat-restricted diets. The new offerings include options such as gastrointestinal low-fat, hydrolyzed protein canine and gastrointestinal hydrolyzed protein feline, all formulated with highly digestible ingredients to promote long-term gastrointestinal health.

Who Are The Prominent Players Across The Animal Gastroesophageal Reflux Disease Market?

North America was the largest region in the animal gastroesophageal reflux disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal gastroesophageal reflux disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access The Complete Animal Gastroesophageal Reflux Disease Market Report:

https://www.thebusinessresearchcompany.com/report/animal-gastroesophageal-reflux-disease-global-market-report

Which Region Leads The Animal Gastroesophageal Reflux Disease Market By Size?

North America was the largest region in the animal gastroesophageal reflux disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal gastroesophageal reflux disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Animal Gastroesophageal Reflux Disease Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=20464&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Active Pharmaceutical Ingredients Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The animal gastroesophageal reflux disease market has shown robust expansion in recent years. Its value is expected to increase from $1.98 billion in 2025 to $2.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.8%. The growth observed in prior periods is attributable to factors including limited awareness of animal GERD among veterinarians, a high prevalence of GERD in companion animals, a shortage of advanced diagnostics in veterinary hospitals, a reliance on generic medications, and the increasing number of veterinary clinics and hospitals.

The market for animal gastroesophageal reflux disease is projected to experience substantial growth over the coming years, reaching $2.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.5%. This anticipated expansion throughout the forecast period is driven by factors such as the advancement of diagnostic methods like endoscopy and manometry, a heightened emphasis on nutritional and dietary management, increased uptake of both over-the-counter and prescription medications, the broadening reach of veterinary e-commerce, and the incorporation of AI and digital platforms to deliver tailored treatments. Key trends expected during this period involve a greater acceptance of endoscopy and pH monitoring for GERD diagnosis, an increase in the application of nutritional supplements and dietary adjustments in patient management, enhanced availability of prescription and OTC drugs for pets, the proliferation of minimally invasive surgical options for GERD therapy, and the development of personalized treatment plans for both livestock and companion animals.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20464&type=smp

What Drivers Are Influencing The Active Pharmaceutical Ingredients Market?

The increasing humanization of pets is anticipated to drive the expansion of the animal gastroesophageal reflux disease market. This trend involves pet owners treating their animals as akin to human family members, attributing human emotions, requirements, and behaviors to them. The growing emotional connections between owners and their pets fuel this humanization, leading to a heightened need for specialized healthcare, high-quality diets, and wellness products that align with human expectations. Furthermore, the humanization of pets raises awareness of conditions such as gastroesophageal reflux disease (GERD), prompting more vigilant owners to seek veterinary attention and thereby boosting demand for diagnostic tools, treatments, and preventive measures. For example, in April 2024, data from the American Pet Products Association, a US-based not-for-profit industry association, indicated that 86.9 million households in the US owned a pet in 2023-2024, representing 66% of households, an increase from 62% in 2022. Thus, the increasing humanization of pets is a key factor propelling the growth of the animal gastroesophageal reflux disease market.

What Major Segment Divisions Exist Within The Active Pharmaceutical Ingredients Market?

The animal gastroesophageal reflux disease market covered in this report is segmented –

1) By Product: Treatment, Diagnostics

2) By Mode: Over-The-Counter (OTC), Prescription

3) By Route Of Administration: Oral, Injectable

4) By Animal: Companion Animals, Livestock Animal

5) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, E-Commerce

Subsegments:

1) By Treatment: Medications, Surgical Interventions, Dietary Modifications, Nutritional Supplements, Antacids

2) By Diagnostics: Endoscopy, Esophageal pH Monitoring, Manometry, Ultrasound, Radiographic Studies, Biopsy Techniques

How Are Trends Shaping The Direction Of The Animal Gastroesophageal Reflux Disease Market?

Leading companies in the animal gastroesophageal reflux disease market are developing specialized diets to support gastrointestinal health, thereby improving digestive function and managing GERD symptoms in pets. Gastrointestinal support diets represent specifically formulated pet foods designed to alleviate and control the manifestations of gastrointestinal disorders. These dietary solutions typically incorporate easily digestible components, balanced nutritional profiles, and added fibers or probiotics to foster digestive well-being and overall health. For example, in April 2024, Royal Canin, a USA-based subsidiary of Mars Incorporated and a producer of cat and dog food, expanded its veterinary gastrointestinal (GI) portfolio by introducing five new diets aimed at enhancing the gastrointestinal health of pets. These specialized diets, developed in collaboration with researchers, veterinarians, and specialists, are focused on addressing GI issues in both dogs and cats, including food-responsive sensitivities and fat-restricted requirements. The new products feature options such as gastrointestinal low-fat, hydrolyzed protein canine, and gastrointestinal hydrolyzed protein feline, all meticulously formulated with highly digestible ingredients to promote long-term gastrointestinal health.

Which Companies Are Leading Innovation In The Active Pharmaceutical Ingredients Market?

Major companies operating in the animal gastroesophageal reflux disease market are Zoetis Inc., VCA Animal Hospitals, Petco Health and Wellness Company Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Hill’s Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Santé Animale, Virbac S.A., Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Blue Buffalo Company Ltd., Vetoquinol S.A., Antech Diagnostics, Heska Corporation, WellPet LLC, McNeil Consumer Pharmaceuticals Co., Wag Labs Inc. , VetPartners Limited, BioZyme Inc., Zomedica Corp., NexGen Pharmaceuticals LLC

Read the full animal gastroesophageal reflux disease market report here:

https://www.thebusinessresearchcompany.com/report/animal-gastroesophageal-reflux-disease-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Active Pharmaceutical Ingredients Market?

North America was the largest region in the animal gastroesophageal reflux disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal gastroesophageal reflux disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Active Pharmaceutical Ingredients Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20464&type=smp

Browse Through More Reports Similar to the Global Animal Gastroesophageal Reflux Disease Market 2026, By The Business Research Company

Gastroesophageal Reflux Disease Therapeutics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-therapeutics-global-market-report

Animal Therapeutics And Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-therapeutics-and-diagnostics-global-market-report

Animal Biotechnology Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-biotechnology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Active Pharmaceutical Ingredients Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The animal gastroesophageal reflux disease market has shown robust expansion in recent years. Its value is expected to increase from $1.98 billion in 2025 to $2.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.8%. The growth observed in prior periods is attributable to factors including limited awareness of animal GERD among veterinarians, a high prevalence of GERD in companion animals, a shortage of advanced diagnostics in veterinary hospitals, a reliance on generic medications, and the increasing number of veterinary clinics and hospitals.

The market for animal gastroesophageal reflux disease is projected to experience substantial growth over the coming years, reaching $2.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.5%. This anticipated expansion throughout the forecast period is driven by factors such as the advancement of diagnostic methods like endoscopy and manometry, a heightened emphasis on nutritional and dietary management, increased uptake of both over-the-counter and prescription medications, the broadening reach of veterinary e-commerce, and the incorporation of AI and digital platforms to deliver tailored treatments. Key trends expected during this period involve a greater acceptance of endoscopy and pH monitoring for GERD diagnosis, an increase in the application of nutritional supplements and dietary adjustments in patient management, enhanced availability of prescription and OTC drugs for pets, the proliferation of minimally invasive surgical options for GERD therapy, and the development of personalized treatment plans for both livestock and companion animals.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20464&type=smp

What Drivers Are Influencing The Active Pharmaceutical Ingredients Market?

The increasing humanization of pets is anticipated to drive the expansion of the animal gastroesophageal reflux disease market. This trend involves pet owners treating their animals as akin to human family members, attributing human emotions, requirements, and behaviors to them. The growing emotional connections between owners and their pets fuel this humanization, leading to a heightened need for specialized healthcare, high-quality diets, and wellness products that align with human expectations. Furthermore, the humanization of pets raises awareness of conditions such as gastroesophageal reflux disease (GERD), prompting more vigilant owners to seek veterinary attention and thereby boosting demand for diagnostic tools, treatments, and preventive measures. For example, in April 2024, data from the American Pet Products Association, a US-based not-for-profit industry association, indicated that 86.9 million households in the US owned a pet in 2023-2024, representing 66% of households, an increase from 62% in 2022. Thus, the increasing humanization of pets is a key factor propelling the growth of the animal gastroesophageal reflux disease market.

What Major Segment Divisions Exist Within The Active Pharmaceutical Ingredients Market?

The animal gastroesophageal reflux disease market covered in this report is segmented –

1) By Product: Treatment, Diagnostics

2) By Mode: Over-The-Counter (OTC), Prescription

3) By Route Of Administration: Oral, Injectable

4) By Animal: Companion Animals, Livestock Animal

5) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, E-Commerce

Subsegments:

1) By Treatment: Medications, Surgical Interventions, Dietary Modifications, Nutritional Supplements, Antacids

2) By Diagnostics: Endoscopy, Esophageal pH Monitoring, Manometry, Ultrasound, Radiographic Studies, Biopsy Techniques

How Are Trends Shaping The Direction Of The Animal Gastroesophageal Reflux Disease Market?

Leading companies in the animal gastroesophageal reflux disease market are developing specialized diets to support gastrointestinal health, thereby improving digestive function and managing GERD symptoms in pets. Gastrointestinal support diets represent specifically formulated pet foods designed to alleviate and control the manifestations of gastrointestinal disorders. These dietary solutions typically incorporate easily digestible components, balanced nutritional profiles, and added fibers or probiotics to foster digestive well-being and overall health. For example, in April 2024, Royal Canin, a USA-based subsidiary of Mars Incorporated and a producer of cat and dog food, expanded its veterinary gastrointestinal (GI) portfolio by introducing five new diets aimed at enhancing the gastrointestinal health of pets. These specialized diets, developed in collaboration with researchers, veterinarians, and specialists, are focused on addressing GI issues in both dogs and cats, including food-responsive sensitivities and fat-restricted requirements. The new products feature options such as gastrointestinal low-fat, hydrolyzed protein canine, and gastrointestinal hydrolyzed protein feline, all meticulously formulated with highly digestible ingredients to promote long-term gastrointestinal health.

Which Companies Are Leading Innovation In The Active Pharmaceutical Ingredients Market?

Major companies operating in the animal gastroesophageal reflux disease market are Zoetis Inc., VCA Animal Hospitals, Petco Health and Wellness Company Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Hill’s Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Santé Animale, Virbac S.A., Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Blue Buffalo Company Ltd., Vetoquinol S.A., Antech Diagnostics, Heska Corporation, WellPet LLC, McNeil Consumer Pharmaceuticals Co., Wag Labs Inc. , VetPartners Limited, BioZyme Inc., Zomedica Corp., NexGen Pharmaceuticals LLC

Read the full animal gastroesophageal reflux disease market report here:

https://www.thebusinessresearchcompany.com/report/animal-gastroesophageal-reflux-disease-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Active Pharmaceutical Ingredients Market?

North America was the largest region in the animal gastroesophageal reflux disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal gastroesophageal reflux disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Active Pharmaceutical Ingredients Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20464&type=smp

Browse Through More Reports Similar to the Global Animal Gastroesophageal Reflux Disease Market 2026, By The Business Research Company

Gastroesophageal Reflux Disease Therapeutics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-therapeutics-global-market-report

Animal Therapeutics And Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-therapeutics-and-diagnostics-global-market-report

Animal Biotechnology Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-biotechnology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Active Pharmaceutical Ingredients Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The animal gastroesophageal reflux disease market has shown robust expansion in recent years. Its value is expected to increase from $1.98 billion in 2025 to $2.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.8%. The growth observed in prior periods is attributable to factors including limited awareness of animal GERD among veterinarians, a high prevalence of GERD in companion animals, a shortage of advanced diagnostics in veterinary hospitals, a reliance on generic medications, and the increasing number of veterinary clinics and hospitals.

The market for animal gastroesophageal reflux disease is projected to experience substantial growth over the coming years, reaching $2.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.5%. This anticipated expansion throughout the forecast period is driven by factors such as the advancement of diagnostic methods like endoscopy and manometry, a heightened emphasis on nutritional and dietary management, increased uptake of both over-the-counter and prescription medications, the broadening reach of veterinary e-commerce, and the incorporation of AI and digital platforms to deliver tailored treatments. Key trends expected during this period involve a greater acceptance of endoscopy and pH monitoring for GERD diagnosis, an increase in the application of nutritional supplements and dietary adjustments in patient management, enhanced availability of prescription and OTC drugs for pets, the proliferation of minimally invasive surgical options for GERD therapy, and the development of personalized treatment plans for both livestock and companion animals.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20464&type=smp

What Drivers Are Influencing The Active Pharmaceutical Ingredients Market?

The increasing humanization of pets is anticipated to drive the expansion of the animal gastroesophageal reflux disease market. This trend involves pet owners treating their animals as akin to human family members, attributing human emotions, requirements, and behaviors to them. The growing emotional connections between owners and their pets fuel this humanization, leading to a heightened need for specialized healthcare, high-quality diets, and wellness products that align with human expectations. Furthermore, the humanization of pets raises awareness of conditions such as gastroesophageal reflux disease (GERD), prompting more vigilant owners to seek veterinary attention and thereby boosting demand for diagnostic tools, treatments, and preventive measures. For example, in April 2024, data from the American Pet Products Association, a US-based not-for-profit industry association, indicated that 86.9 million households in the US owned a pet in 2023-2024, representing 66% of households, an increase from 62% in 2022. Thus, the increasing humanization of pets is a key factor propelling the growth of the animal gastroesophageal reflux disease market.

What Major Segment Divisions Exist Within The Active Pharmaceutical Ingredients Market?

The animal gastroesophageal reflux disease market covered in this report is segmented –

1) By Product: Treatment, Diagnostics

2) By Mode: Over-The-Counter (OTC), Prescription

3) By Route Of Administration: Oral, Injectable

4) By Animal: Companion Animals, Livestock Animal

5) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, E-Commerce

Subsegments:

1) By Treatment: Medications, Surgical Interventions, Dietary Modifications, Nutritional Supplements, Antacids

2) By Diagnostics: Endoscopy, Esophageal pH Monitoring, Manometry, Ultrasound, Radiographic Studies, Biopsy Techniques

How Are Trends Shaping The Direction Of The Animal Gastroesophageal Reflux Disease Market?

Leading companies in the animal gastroesophageal reflux disease market are developing specialized diets to support gastrointestinal health, thereby improving digestive function and managing GERD symptoms in pets. Gastrointestinal support diets represent specifically formulated pet foods designed to alleviate and control the manifestations of gastrointestinal disorders. These dietary solutions typically incorporate easily digestible components, balanced nutritional profiles, and added fibers or probiotics to foster digestive well-being and overall health. For example, in April 2024, Royal Canin, a USA-based subsidiary of Mars Incorporated and a producer of cat and dog food, expanded its veterinary gastrointestinal (GI) portfolio by introducing five new diets aimed at enhancing the gastrointestinal health of pets. These specialized diets, developed in collaboration with researchers, veterinarians, and specialists, are focused on addressing GI issues in both dogs and cats, including food-responsive sensitivities and fat-restricted requirements. The new products feature options such as gastrointestinal low-fat, hydrolyzed protein canine, and gastrointestinal hydrolyzed protein feline, all meticulously formulated with highly digestible ingredients to promote long-term gastrointestinal health.

Which Companies Are Leading Innovation In The Active Pharmaceutical Ingredients Market?

Major companies operating in the animal gastroesophageal reflux disease market are Zoetis Inc., VCA Animal Hospitals, Petco Health and Wellness Company Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Hill’s Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Santé Animale, Virbac S.A., Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Blue Buffalo Company Ltd., Vetoquinol S.A., Antech Diagnostics, Heska Corporation, WellPet LLC, McNeil Consumer Pharmaceuticals Co., Wag Labs Inc. , VetPartners Limited, BioZyme Inc., Zomedica Corp., NexGen Pharmaceuticals LLC

Read the full animal gastroesophageal reflux disease market report here:

https://www.thebusinessresearchcompany.com/report/animal-gastroesophageal-reflux-disease-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Active Pharmaceutical Ingredients Market?

North America was the largest region in the animal gastroesophageal reflux disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal gastroesophageal reflux disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Active Pharmaceutical Ingredients Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20464&type=smp

Browse Through More Reports Similar to the Global Animal Gastroesophageal Reflux Disease Market 2026, By The Business Research Company

Gastroesophageal Reflux Disease Therapeutics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-therapeutics-global-market-report

Animal Therapeutics And Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-therapeutics-and-diagnostics-global-market-report

Animal Biotechnology Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-biotechnology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the aluminum bottles market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Animal Gastroesophageal Reflux Disease Market’s size between 2026 and 2030?

The market size for animal gastroesophageal reflux disease has experienced significant growth over recent years. This market is projected to expand from $1.98 billion in 2025 to $2.16 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.8%. Historically, this growth has been influenced by factors such as veterinarians’ limited understanding of animal GERD, the widespread occurrence of GERD in companion animals, insufficient advanced diagnostic tools in veterinary hospitals, the dependence on generic drugs, and the increasing number of veterinary clinics and hospitals.

The animal gastroesophageal reflux disease market size is projected to experience substantial growth in the coming years, with expectations to reach $2.99 billion in 2030, expanding at a compound annual growth rate (CAGR) of 8.5%. This growth throughout the forecast period is driven by factors such as the development of advanced diagnostic techniques like endoscopy and manometry, a growing emphasis on nutritional and dietary interventions, the increasing adoption of both over-the-counter and prescription drugs, the expansion of veterinary e-commerce channels, and the integration of AI and digital platforms to provide personalized treatment. Major trends anticipated in this period include a rising use of endoscopy and pH monitoring for GERD diagnosis, an increased application of nutritional supplements and dietary modifications in its management, a broader availability of prescription and OTC medications for companion animals, the expansion of minimally invasive surgical interventions for GERD treatment, and the development of customized treatment protocols for livestock and companion animals.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20464&type=smp

Which Drivers Are Shaping Strategic Decisions In The Animal Gastroesophageal Reflux Disease Market?

The rising trend of pet humanization is anticipated to boost expansion within the animal gastroesophageal reflux disease market. This humanization of pets describes a developing pattern where individuals consider their animal companions as members of their own families, assigning them human-like feelings, requirements, and actions. The deepening emotional connections between owners and their pets fuel this inclination towards humanizing animals, which in turn elevates the need for specialized medical care, high-quality diets, and wellness items comparable to those for humans. Furthermore, pet humanization enhances understanding of health conditions like gastroesophageal reflux disease (GERD), motivating more vigilant owners to pursue veterinary attention and thereby increasing the need for diagnostic tools, therapies, and preventative measures. For instance, in April 2024, according to the American Pet Products Association, a US-based not-for-profit industry association, 86.9 million households in the US had a pet in 2023-2024, accounting for 66% of households, up from 62% in 2022. Consequently, the increasing humanization of pets is accelerating the growth of the animal gastroesophageal reflux disease market.

What Segment Classifications Make Up The Animal Gastroesophageal Reflux Disease Market?

The animal gastroesophageal reflux disease market covered in this report is segmented –

1) By Product: Treatment, Diagnostics

2) By Mode: Over-The-Counter (OTC), Prescription

3) By Route Of Administration: Oral, Injectable

4) By Animal: Companion Animals, Livestock Animal

5) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, E-Commerce

Subsegments:

1) By Treatment: Medications, Surgical Interventions, Dietary Modifications, Nutritional Supplements, Antacids

2) By Diagnostics: Endoscopy, Esophageal pH Monitoring, Manometry, Ultrasound, Radiographic Studies, Biopsy Techniques

What Long-Term Trends Are Expected To Shape The Future Of The Animal Gastroesophageal Reflux Disease Market?

Major companies active in the animal gastroesophageal reflux disease market are creating specific diets that aid gastrointestinal health to enhance digestive function and alleviate symptoms of gastroesophageal reflux disease in pets. Gastrointestinal support diets represent precisely formulated pet foods intended to manage and reduce the indicators of gastrointestinal disorders. These diets usually contain ingredients that are easily digestible, balanced nutrients, and additional fibers or probiotics to support digestive well-being and general health. For instance, in April 2024, Royal Canin, a USA-based subsidiary of Mars Incorporated and a manufacturer of cat and dog food, broadened its veterinary gastrointestinal (GI) product line by introducing five new diets aimed at improving the gastrointestinal health of pets. These specialized diets, developed through cooperation with researchers, veterinarians, and specialists, concentrate on addressing GI problems in both dogs and cats, including sensitivities responsive to food and fat-restricted dietary needs. The new offerings include varieties such as gastrointestinal low-fat, hydrolyzed protein canine, and gastrointestinal hydrolyzed protein feline, all made with highly digestible components to encourage sustained gastrointestinal health.

Which Major Firms Are Strengthening Their Position In The Animal Gastroesophageal Reflux Disease Market?

Major companies operating in the animal gastroesophageal reflux disease market are Zoetis Inc., VCA Animal Hospitals, Petco Health and Wellness Company Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Hill’s Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Santé Animale, Virbac S.A., Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Blue Buffalo Company Ltd., Vetoquinol S.A., Antech Diagnostics, Heska Corporation, WellPet LLC, McNeil Consumer Pharmaceuticals Co., Wag Labs Inc. , VetPartners Limited, BioZyme Inc., Zomedica Corp., NexGen Pharmaceuticals LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/animal-gastroesophageal-reflux-disease-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Animal Gastroesophageal Reflux Disease Market?

North America was the largest region in the animal gastroesophageal reflux disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal gastroesophageal reflux disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Animal Gastroesophageal Reflux Disease Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20464&type=smp

Browse Through More Reports Similar to the Global Animal Gastroesophageal Reflux Disease Market 2026, By The Business Research Company

Gastroesophageal Reflux Disease Therapeutics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-therapeutics-global-market-report

Animal Therapeutics And Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-therapeutics-and-diagnostics-global-market-report

Animal Biotechnology Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-biotechnology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Animal Gastroesophageal Reflux Disease Market?

The escalating trend of treating pets much like human family members, known as pet humanization, is projected to boost the animal gastroesophageal reflux disease market. This ongoing shift in perception involves attributing anthropomorphic feelings, wants, and actions to pets, fueled by the deepening emotional connectivity between owners and their pets. Consequently, this raises the demand for healthcare tailored to pets’ needs, high-end diets, and health products that conform to human standards. As pet humanization intensifies, it raises awareness regarding health issues such as gastroesophageal reflux disease (GERD), leading discerning pet owners to seek veterinary help. This ups the requirement for diagnostics, treatments, and preventive measures. For example, data from the American Pet Products Association in April 2024 revealed that 86.9 million households in the US owned a pet in 2023-2024, which represents 66% of households, a rise from 62% in 2022. Hence, the escalating humanization of pets is fuelling the development of the animal gastroesophageal reflux disease market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20464&type=smp

#What Are the Key Projections for the CAGR of the Animal Gastroesophageal Reflux Disease Market From 2025 to 2034?

In recent years, the animal gastroesophageal reflux disease market has seen a robust growth. This market, expected to progress from $1.82 billion in 2024 to $1.98 billion in 2025, boasts a compound annual growth rate (CAGR) of 8.9%. The impressive growth during past years is credited to several factors: a rise in pet obesity, advances in diagnostic technologies in the veterinary field, heightened awareness pertaining to gastrointestinal disorders in pets, enhanced veterinary care and treatment methods, an upswing in pet ownership and pet health expenditure, as well as the evolution of specialised veterinary pharmaceuticals and meal plans.

The market for animal gastroesophageal reflux disease is projected to witness robust expansion in the coming years, escalating to $2.76 billion by 2029 with a compound annual growth rate (CAGR) of 8.6%. The surge in the estimated period can be linked to the augmenting frequency of gastrointestinal ailments in household animals, the rising demand for progressive diagnostic and therapeutic alternatives, the growth in consciousness and understanding regarding animal health, the increase in pet insurance and veterinary care, advancements in animal health pharmaceuticals and therapies, elevated disposable income, and readiness to invest in animal wellbeing. Major market tendencies predicted for this duration encompass specialized and customized treatment options, the application of advanced diagnostic tools and technology, improvement in veterinary practices and services, preventative care and nutrition management and the cooperation between veterinary experts and pet guardians.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20464

What New Market Trends Are Reshaping theAnimal Gastroesophageal Reflux Disease Market and Its Opportunities?

Significant players in the animal gastroesophageal reflux disease market are focusing on the creation of specialized diets that bolster gastrointestinal health and help control gastroesophageal reflux disease symptoms in pets. These gastrointestinal support diets are uniquely formulated pet food products aimed at managing and reducing gastrointestinal disorder symptoms. They generally include ingredients that are easy to digest, nutritionally balanced, and contain added fibers or probiotics for improved digestive health and overall wellness. For instance, Royal Canin USA, a Mars Incorporated subsidiary and pet food producer, extended its range of veterinary gastrointestinal products in April 2024 by launching five new pet diets to boost pets’ gastrointestinal welfare. These individualized diets are created in partnership with researchers, veterinarians, and specialists and are intended to address GI problems in both canines and felines, encompassing food-responsive sensitivities and fat-restricted diets. The recent additions include options like gastrointestinal low-fat, hydrolyzed protein canine, and gastrointestinal hydrolyzed protein feline, all made with ingredients that are highly digestible to encourage lasting gastrointestinal health.

Who Are the Leading Market Players Fueling Growth in the Animal Gastroesophageal Reflux Disease Market Trend?

Major companies operating in the animal gastroesophageal reflux disease market are Zoetis Inc., VCA Animal Hospitals, Petco Health and Wellness Company Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Hill’s Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Santé Animale, Virbac S.A., Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Blue Buffalo Company Ltd., Vetoquinol S.A., Antech Diagnostics, Heska Corporation, WellPet LLC, McNeil Consumer Pharmaceuticals Co., Wag Labs Inc., VetPartners Limited, BioZyme Inc., Zomedica Corp., NexGen Pharmaceuticals LLC

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/animal-gastroesophageal-reflux-disease-global-market-report

How is the Global Animal Gastroesophageal Reflux Disease Market Segemented?

The animal gastroesophageal reflux disease market covered in this report is segmented –

1) By Product: Treatment, Diagnostics

2) By Mode: Over-The-Counter (OTC), Prescription

3) By Route Of Administration: Oral, Injectable

4) By Animal: Companion Animals, Livestock Animal

5) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, E-Commerce

Subsegments:

1) By Treatment: Medications, Surgical Interventions, Dietary Modifications, Nutritional Supplements, Antacids

2) By Diagnostics: Endoscopy, Esophageal pH Monitoring, Manometry, Ultrasound, Radiographic Studies, Biopsy Techniques

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=20464&type=smp

Which Geographics are Influencing the Growth of the Animal Gastroesophageal Reflux Disease Market?

North America was the largest region in the animal gastroesophageal reflux disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal gastroesophageal reflux disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Animal Gastroesophageal Reflux Disease Market 2025, By The Business Research Company:

Gastroesophageal Reflux Disease (GERD) Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-gerd-global-market-report

Gastroesophageal Reflux Disease Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-therapeutics-global-market-report

Global Animal Therapeutics And Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-therapeutics-and-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 15% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!

How has the animal gastroesophageal reflux disease market grown in recent years?

In recent times, the animal gastroesophageal reflux disease market has seen robust growth. A surge from $1.82 billion in 2024 to $1.98 billion in 2025 is anticipated, marking a compound annual growth rate (CAGR) of 8.9%. Factors contributing to this growth in the past include rising pet obesity statistics, advancements in veterinary diagnostic methodologies, increasing consciousness regarding gastrointestinal issues in pets, enhanced veterinary care and treatment choices, a rise in pet ownership and spending on pet health, as well as the emergence of specialty veterinary drugs and diets.

How is the animal gastroesophageal reflux disease market size expected to evolve during the forecast period?

The market for gastroesophageal reflux disease in animals is projected to experience notable expansion in the coming years, surging to a value of $2.76 billion by 2029, with a compound annual growth rate (CAGR) of 8.6%. The anticipated growth during the forecast timeline can be credited to factors such as increasing prevalence of gastrointestinal disorders in pets, amplified demand for superior diagnostic and treatment approaches, heightened awareness and knowledge regarding pet well-being, broader pet insurance coverage and veterinary services, progress in veterinary pharmaceuticals and treatments, rising disposable incomes, and readiness to invest in pet health. Key trends for the forecast period consist of differentiated and personalized treatment options, adoption of cutting-edge diagnostic instruments and technologies, veterinary procedures and services, preventive care and dietary management, and collaborations between veterinary experts and pet owners.

Get your animal gastroesophageal reflux disease market report here!

https://www.thebusinessresearchcompany.com/report/animal-gastroesophageal-reflux-disease-global-market-report

Which key drivers are propelling the animal gastroesophageal reflux disease market’s growth?

The rise in pet humanization is anticipated to fuel the expansion of the animal gastroesophageal reflux disease segment. Pet humanization refers to the emerging practice of pet owners treating their pets akin to human family members, assigning them human-like feelings, requirements, and actions. The increasing emotional bond between pet owners and their pets drives this trend, which elevates the demand for niche health services, premium food items, and wellness products that match human norms. Pet humanization strengthens the understanding of health problems such as gastroesophageal reflux disease (GERD), encouraging more attentive owners to pursue veterinary treatment and increasing the demand for diagnostics, treatments, and preventive measures. For example, in April 2024, the American Pet Products Association, a US-based non-profit industry body, stated that there were 86.9 million households in the US with a pet in 2023-2024, representing 66% of households, a rise from 62% in 2022. Thus, the growth of pet humanization is leading to the advancement of the animal gastroesophageal reflux disease industry.

What are the market segments in the animal gastroesophageal reflux disease industry?

The animal gastroesophageal reflux disease market covered in this report is segmented –

1) By Product: Treatment, Diagnostics

2) By Mode: Over-The-Counter (OTC), Prescription

3) By Route Of Administration: Oral, Injectable

4) By Animal: Companion Animals, Livestock Animal

5) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, E-Commerce

Subsegments:

1) By Treatment: Medications, Surgical Interventions, Dietary Modifications, Nutritional Supplements, Antacids

2) By Diagnostics: Endoscopy, Esophageal pH Monitoring, Manometry, Ultrasound, Radiographic Studies, Biopsy Techniques

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20464&type=smp

Which leading companies are shaping the growth of the animal gastroesophageal reflux disease market?

Major companies operating in the animal gastroesophageal reflux disease market are Zoetis Inc., VCA Animal Hospitals, Petco Health and Wellness Company Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Hill’s Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Santé Animale, Virbac S.A., Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Blue Buffalo Company Ltd., Vetoquinol S.A., Antech Diagnostics, Heska Corporation, WellPet LLC, McNeil Consumer Pharmaceuticals Co., Wag Labs Inc., VetPartners Limited, BioZyme Inc., Zomedica Corp., NexGen Pharmaceuticals LLC

What key trends are currently impacting the animal gastroesophageal reflux disease market’s development?

Leading companies in the animal gastroesophageal reflux disease market are creating unique gastrointestinal supportive diets to enhance digestive wellness and regulate symptoms of gastroesophageal reflux disease in pets. These specially designed pet foods help manage and ease symptoms related to gastrointestinal disorders. Such diets usually contain ingredients that are easy to digest, balanced nutrients, and extra fiber or probiotics to improve digestive wellness and overall health. For example, in April 2024, Royal Canin USA, a Mars Incorporated branch that manufactures cat and dog food, increased its veterinary gastrointestinal (GI) offerings by launching five new diets aimed at boosting pets’ gastrointestinal wellness. These special diets, created in partnership with researchers, veterinarians, and experts, are designed to tackle GI problems in dogs and cats, including food-induced sensitivities and fat-limited diets. The new products feature options like gastrointestinal low-fat, hydrolyzed protein canine and gastrointestinal hydrolyzed protein feline, all made with highly digestible ingredients to support ongoing gastrointestinal health.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20464

Which geographic areas are influencing the growth of the animal gastroesophageal reflux disease market?

North America was the largest region in the animal gastroesophageal reflux disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal gastroesophageal reflux disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Gastroesophageal Reflux Disease (GERD) Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-gerd-global-market-report

Gastroesophageal Reflux Disease Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-therapeutics-global-market-report

Global Animal Therapeutics And Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-therapeutics-and-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Growth Rate of the Animal Gastroesophageal Reflux Disease Market Shape Industry Trends by 2034?

Recent years have seen a marked increase in the size of the animal gastroesophageal reflux disease market. Its expansion from $1.82 billion in 2024 to $1.98 billion in 2025, displaying a compound annual growth rate (CAGR) of 8.9%, can be attributed to various factors. The key contributors include the rise in obesity amongst pets, advancements made in veterinary diagnostic technologies, increased awareness regarding pets’ gastrointestinal disorders, better treatment options and veterinary care, growing pet ownership coupled with additional spending on their health, and the production of specialized veterinary pharmaceuticals and diets.

The market size for animal gastroesophageal reflux disease is projected to experience significant expansion in the following years, reaching $2.76 billion in 2029 with a compound annual growth rate (CAGR) of 8.6%. This surge during the prediction period is associated with the increased incidence of gastrointestinal disorders in pets, heightened demand for sophisticated diagnostic and treatment procedures, enhanced knowledge and understanding of pet healthcare, broader pet insurance and veterinary service provisions, advancements in veterinary drugs and treatments, a rise in disposable income, and a greater propensity to invest in pet health. During this forecast period, key trends to watch include more specialized and customized treatment choices, the use of innovative diagnostic equipment and methods, veterinary practices and services, preventive care and dietary control, and cooperation between veterinary specialists and pet owners.

What Major Innovations Are Driving the Accelerated Growth of the Animal Gastroesophageal Reflux Disease Market?

The growth of the animal gastroesophageal reflux disease market is being fuelled by the rising trend of humanizing pets. Pet owners are increasingly treating their pets as akin to human family members, attributing them with human-like feelings, necessities, and behaviors. The evolution of emotional ties between pet owners and their pets is driving this pet humanization trend. As a result, there’s a heightened demand for specialized healthcare, luxury diets, and health and wellness products aligning with human standards. Pet humanization amplifies the recognition of health conditions like gastroesophageal reflux disease (GERD), causing more vigilant owners to opt for veterinary care and accelerating demand for diagnostics, treatments, and preventive measures. As an example, in 2024, the American Pet Products Association, a non-profit industry association in the US, stated that 86.9 million US households had a pet in 2023-2024 constituting 66% of households, a rise from 62% in 2022. Thus, the escalating trend of pet humanization is contributing to the expansion of the animal gastroesophageal reflux disease market.

Get Your Free Sample of the Global Animal Gastroesophageal Reflux Disease Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=20464&type=smp

Who Are the Key Market Players Influencing the Growth of the Animal Gastroesophageal Reflux Disease Industry?

Major companies operating in the animal gastroesophageal reflux disease market are:

• Zoetis Inc._x000D_

• VCA Animal Hospitals_x000D_

• Petco Health and Wellness Company Inc._x000D_

• Merck Animal Health_x000D_

• Boehringer Ingelheim Animal Health_x000D_

What Key Market Trends Are Shaping the Future of the Animal Gastroesophageal Reflux Disease Industry?

Leading companies in the animal gastroesophageal reflux disease market, are introducing custom-made diets to support the digestive health of pets and to control the signs of the disease. These tailored meals, known as gastrointestinal support diets, are created especially to alleviate the symptoms of gastrointestinal disorders. Comprising of easy to digest content, balanced nutrients, and supplementary fibers or probiotics, these diets aim to boost digestive health and overall fitness. An example of this was witnessed in April 2024 when Royal Canin USA, an offshoot of Mars Incorporated and a cat and dog food manufacturing company, extended its veterinary gastrointestinal (GI) range by launching five new diets to enhance pets’ gastrointestinal health. These highly specialized diets were devised in partnership with researchers, veterinarians, and experts to focus on the GI problems in both dogs and cats, including issues like diet-responsive sensitivities and fat-restrictive diets. The new line introduces alternatives like gastrointestinal low-fat, hydrolyzed protein canine, and gastrointestinal hydrolyzed protein feline, all made from easily digestible components to ensure prolonged gastrointestinal health.

Get Instant Access to the Global Animal Gastroesophageal Reflux Disease Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/animal-gastroesophageal-reflux-disease-global-market-report

What Are the Main Segments of the Animal Gastroesophageal Reflux Disease Market, and How Are They Evolving?

The animal gastroesophageal reflux disease market covered in this report is segmented –

1) By Product: Treatment, Diagnostics

2) By Mode: Over-The-Counter (OTC), Prescription

3) By Route Of Administration: Oral, Injectable

4) By Animal: Companion Animals, Livestock Animal

5) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, E-Commerce

Subsegments:

1) By Treatment: Medications, Surgical Interventions, Dietary Modifications, Nutritional Supplements, Antacids

2) By Diagnostics: Endoscopy, Esophageal pH Monitoring, Manometry, Ultrasound, Radiographic Studies, Biopsy Techniques

Which Regions Are Emerging as Leaders in the Animal Gastroesophageal Reflux Disease Market?

North America was the largest region in the animal gastroesophageal reflux disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal gastroesophageal reflux disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Defining Features of the Animal Gastroesophageal Reflux Disease Market?

Animal gastroesophageal reflux disease (GERD) is a condition where stomach acid or bile flows back into the esophagus, causing irritation and inflammation. The condition can lead to symptoms such as vomiting, regurgitation, weight loss, or discomfort during eating. The purpose of diagnosing and treating GERD in animals is to prevent discomfort, improve their quality of life, and avoid complications such as esophagitis, ulcers, or stricture formation.

Browse Through More Similar Reports By The Business Research Company:

Gastroesophageal Reflux Disease (GERD) Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-gerd-global-market-report

Gastroesophageal Reflux Disease Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-therapeutics-global-market-report

Global Animal Therapeutics And Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-therapeutics-and-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Growth Rate of the Animal Gastroesophageal Reflux Disease Market Shape Industry Trends by 2034?

Recent years have seen a marked increase in the size of the animal gastroesophageal reflux disease market. Its expansion from $1.82 billion in 2024 to $1.98 billion in 2025, displaying a compound annual growth rate (CAGR) of 8.9%, can be attributed to various factors. The key contributors include the rise in obesity amongst pets, advancements made in veterinary diagnostic technologies, increased awareness regarding pets’ gastrointestinal disorders, better treatment options and veterinary care, growing pet ownership coupled with additional spending on their health, and the production of specialized veterinary pharmaceuticals and diets.

The market size for animal gastroesophageal reflux disease is projected to experience significant expansion in the following years, reaching $2.76 billion in 2029 with a compound annual growth rate (CAGR) of 8.6%. This surge during the prediction period is associated with the increased incidence of gastrointestinal disorders in pets, heightened demand for sophisticated diagnostic and treatment procedures, enhanced knowledge and understanding of pet healthcare, broader pet insurance and veterinary service provisions, advancements in veterinary drugs and treatments, a rise in disposable income, and a greater propensity to invest in pet health. During this forecast period, key trends to watch include more specialized and customized treatment choices, the use of innovative diagnostic equipment and methods, veterinary practices and services, preventive care and dietary control, and cooperation between veterinary specialists and pet owners.

What Major Innovations Are Driving the Accelerated Growth of the Animal Gastroesophageal Reflux Disease Market?

The growth of the animal gastroesophageal reflux disease market is being fuelled by the rising trend of humanizing pets. Pet owners are increasingly treating their pets as akin to human family members, attributing them with human-like feelings, necessities, and behaviors. The evolution of emotional ties between pet owners and their pets is driving this pet humanization trend. As a result, there’s a heightened demand for specialized healthcare, luxury diets, and health and wellness products aligning with human standards. Pet humanization amplifies the recognition of health conditions like gastroesophageal reflux disease (GERD), causing more vigilant owners to opt for veterinary care and accelerating demand for diagnostics, treatments, and preventive measures. As an example, in 2024, the American Pet Products Association, a non-profit industry association in the US, stated that 86.9 million US households had a pet in 2023-2024 constituting 66% of households, a rise from 62% in 2022. Thus, the escalating trend of pet humanization is contributing to the expansion of the animal gastroesophageal reflux disease market.

Get Your Free Sample of the Global Animal Gastroesophageal Reflux Disease Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=20464&type=smp

Who Are the Key Market Players Influencing the Growth of the Animal Gastroesophageal Reflux Disease Industry?

Major companies operating in the animal gastroesophageal reflux disease market are:

• Zoetis Inc._x000D_

• VCA Animal Hospitals_x000D_

• Petco Health and Wellness Company Inc._x000D_

• Merck Animal Health_x000D_

• Boehringer Ingelheim Animal Health_x000D_

What Key Market Trends Are Shaping the Future of the Animal Gastroesophageal Reflux Disease Industry?

Leading companies in the animal gastroesophageal reflux disease market, are introducing custom-made diets to support the digestive health of pets and to control the signs of the disease. These tailored meals, known as gastrointestinal support diets, are created especially to alleviate the symptoms of gastrointestinal disorders. Comprising of easy to digest content, balanced nutrients, and supplementary fibers or probiotics, these diets aim to boost digestive health and overall fitness. An example of this was witnessed in April 2024 when Royal Canin USA, an offshoot of Mars Incorporated and a cat and dog food manufacturing company, extended its veterinary gastrointestinal (GI) range by launching five new diets to enhance pets’ gastrointestinal health. These highly specialized diets were devised in partnership with researchers, veterinarians, and experts to focus on the GI problems in both dogs and cats, including issues like diet-responsive sensitivities and fat-restrictive diets. The new line introduces alternatives like gastrointestinal low-fat, hydrolyzed protein canine, and gastrointestinal hydrolyzed protein feline, all made from easily digestible components to ensure prolonged gastrointestinal health.

Get Instant Access to the Global Animal Gastroesophageal Reflux Disease Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/animal-gastroesophageal-reflux-disease-global-market-report

What Are the Main Segments of the Animal Gastroesophageal Reflux Disease Market, and How Are They Evolving?

The animal gastroesophageal reflux disease market covered in this report is segmented –

1) By Product: Treatment, Diagnostics

2) By Mode: Over-The-Counter (OTC), Prescription

3) By Route Of Administration: Oral, Injectable

4) By Animal: Companion Animals, Livestock Animal

5) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, E-Commerce

Subsegments:

1) By Treatment: Medications, Surgical Interventions, Dietary Modifications, Nutritional Supplements, Antacids

2) By Diagnostics: Endoscopy, Esophageal pH Monitoring, Manometry, Ultrasound, Radiographic Studies, Biopsy Techniques

Which Regions Are Emerging as Leaders in the Animal Gastroesophageal Reflux Disease Market?

North America was the largest region in the animal gastroesophageal reflux disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal gastroesophageal reflux disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Defining Features of the Animal Gastroesophageal Reflux Disease Market?

Animal gastroesophageal reflux disease (GERD) is a condition where stomach acid or bile flows back into the esophagus, causing irritation and inflammation. The condition can lead to symptoms such as vomiting, regurgitation, weight loss, or discomfort during eating. The purpose of diagnosing and treating GERD in animals is to prevent discomfort, improve their quality of life, and avoid complications such as esophagitis, ulcers, or stricture formation.

Browse Through More Similar Reports By The Business Research Company:

Gastroesophageal Reflux Disease (GERD) Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-gerd-global-market-report

Gastroesophageal Reflux Disease Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-therapeutics-global-market-report

Global Animal Therapeutics And Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-therapeutics-and-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: